Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation —a prospective, observational study
Mycophenolate mofetil (MMF) is an established therapy for systemic sclerosis (SSc), but its pharmacokinetics in this disease remains unexplored. We have investigated drug exposure in MMF-treated patients with ...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Kristofer Andr éasson, Karl Neringer, Dirk M. Wuttge, Dan Henrohn, Jan Marsal and Roger Hesselstrand Tags: Research article Source Type: research